Choroquine-resistant Plasmodium falciparum malaria in the United Kingdom.
D000328:Adult; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use*; D004739:England; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D008296:Malaysia; D008297:Male; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D010963:Plasmodium falciparum / Q000187:drug effects*; D011319:Primaquine / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000494:pharmacology / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D010406:Penicillins; D013449:Sulfonamides; D002738:Chloroquine; D011803:Quinine; D011319:Primaquine; D011739:Pyrimethamine